Exelixis (NASDAQ: EXEL) reported Q2 EPS of $0.28, $0.12 better than the analyst estimate of $0.16. Revenue for the quarter came in at $186.1 million versus the consensus estimate of $155.89 million.

For earnings history and earnings-related data on Exelixis (EXEL) click here.